October 23, 2007 – Patients who received the CYPHER Sirolimus-eluting coronary stent had a lower risk of stent ...
October 22, 2007 – A time-motion study conducted at Providence Heart Institute in Columbia, SC, spanning approximately ...
October 22, 2007 – At TCT 2007, ProSolv CardioVascular, a FUJIFILM company, (ProSolv) demonstrated its advanced ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent, researchers reported at TCT 2007.
October 22, 2007 – Stent thrombosis rates through one year were low for both the TAXUS Express2 Paclitaxel-Eluting ...
October 22, 2007 – Philips highlighted the integration of Volcano’s IVUS into its new Xper system and TrueView’s ability ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 22, 2007 - Implantation of the CYPHER Sirolimus-eluting Coronary Stent by Cordis Corp. used to treat completely ...
October 22, 2007 - GE Healthcare highlighted the advantages of its digital flat panel Biplane imaging systems, the ...
The HI VISION 5500 fully digital ultrasound system reportedly delivers the latest generation of signal processing ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 18, 2007 - Boston Scientific Corp. today announced it will restructure or sell several business units to reduce operating expenses by 13 percent in 2008 in a move designed to enhance short- and long-term shareholder value.
October 18, 2007 - This year at TCT ProSolv CardioVascular, a FUJIFILM company and leading provider of enterprise-level ...
October 18, 2007 - Guerbet will feature at TCT 2007 its x-ray contrast agent, Oxilan (ioxilan) injection, a contrast ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 18, 2007 – XTENT Inc. announced that two-year data from the CUSTOM I trial and 1-year data from the CUSTOM II ...
October 18, 2007 - Combining all of the features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi ...
During the last several decades, the prevalence of Methicillin-Resistant Staphylococus Aureus (MRSA) and other ...